These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 7508903)

  • 1. Binding characteristics of (-)-(R)-2-aminomethylpyrrolidine(1,1-cyclobutanedicarboxylato)-2-platin um(II) to DNA, RNA and protein molecules in HeLa cells and its lethal effect: comparison with cis- and trans-diamminedichloroplatinums(II).
    Akaboshi M; Kawai K; Ujeno Y; Takada S; Miyahara T
    Jpn J Cancer Res; 1994 Jan; 85(1):106-11. PubMed ID: 7508903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of the target volume of HeLa cells treated with platinum-195 m radiolabeled cis-diammine(1, 1-cyclobutane-dicarboxylato)-platinum(II); comparison with cis- and trans-diamminedichloroplatinums(II).
    Akaboshi M; Kawai K; Tanaka Y; Sumino T; Masunaga S; Ono K; Miyahara T
    Nucl Med Biol; 1994 Oct; 21(7):953-8. PubMed ID: 9234349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell-killing efficiency and number of platinum atoms binding to DNA, RNA and protein molecules of HeLa cells treated with combinations of trans-diaminedichloroplatinum(II) and hyperthermia.
    Akaboshi M; Kawai K; Kinashi Y; Masunaga S; Ono K
    Jpn J Cancer Res; 1997 May; 88(5):506-11. PubMed ID: 9247608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The number of platinum atoms binding to DNA, RNA and protein molecules of HeLa cells treated with cisplatin at its mean lethal concentration.
    Akaboshi M; Kawai K; Maki H; Akuta K; Ujeno Y; Miyahara T
    Jpn J Cancer Res; 1992 May; 83(5):522-6. PubMed ID: 1618702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of the target volume of HeLa cells treated with platinum-195m radiolabeled trans-diaminedichloroplatinum(II): a comparison with cis-diaminedichloroplatinum(II).
    Akaboshi M; Kawai K; Maki H; Akuta K; Ujeno Y; Ono K; Miyahara T
    Nucl Med Biol; 1993 May; 20(4):389-93. PubMed ID: 8504280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between cell-killing efficiency and number of platinum atoms binding to DNA, RNA, and protein molecules in HeLa cells treated with cis-diamine(glycolato)platinum(II).
    Akaboshi M; Kawai K; Kinashi Y; Masunaga S; Ono K
    Jpn J Cancer Res; 1996 Feb; 87(2):178-83. PubMed ID: 8609067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new anticancer platinum compound, (-)-(R)-2-aminomethyl-pyrrolidine(1,1-cyclobutanedicarboxylato) platinum(II): DNA interstrand crosslinking, repair and lethal effects in normal human, Fanconi's anaemia and xeroderma pigmentosum cells.
    Fujiwara Y; Nakamura M; Yokoo S
    Br J Cancer; 1993 Jun; 67(6):1285-92. PubMed ID: 8512813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumor effects of three platinum complexes, (-)-(R)-2-aminomethylpyrrolidine(1,1-cyclobutanedicarboxylato)-platinum (II) monohydrate (DWA2114R), cis-diammine-(1,1-cyclobutanedicarboxylato)platinum(II) (CBDCA) and cis-diamminedichloroplatinum(II) (CDDP), in mice.
    Endo K; Akamatsu K; Matsumoto T; Morikawa K; Koizumi M; Mitsui H; Koizumi K
    Anticancer Res; 1992; 12(1):49-58. PubMed ID: 1567181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The interactions of (-)-(R)-2-aminomethylpyrrolidine (1,1-cyclobutanedicarboxylato)platinum(II) monohydrate (DWA2114R) and related compounds with deoxyribonucleic acid.
    Morikawa K; Matsumoto T; Matsuoka Y; Koizumi K
    Chem Pharm Bull (Tokyo); 1992 Jan; 40(1):212-9. PubMed ID: 1576676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of hyperthermia on the number of platinum atoms binding to DNA of HeLa cells treated with 195mPt-radiolabelled cis-diaminedichloroplatinum(II).
    Akaboshi M; Tanaka Y; Kawai K; Akuta K; Masunaga S; Ono K
    Int J Radiat Biol; 1994 Aug; 66(2):215-20. PubMed ID: 8089631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell-killing efficiency and number of platinum atoms binding to DNA, RNA, and protein molecules of HeLa cells treated with combinations of hyperthermia and cis-diamine(glycolato)platinum(II).
    Akaboshi M; Kawai K; Tanaka Y; Takada J; Fujii N
    Biol Trace Elem Res; 1999; 71-72():585-93. PubMed ID: 10676535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flow cytometric analyses of the characteristics of tumor cells treated with two platinum compounds: 1,1-cyclobutanedicarboxylato(2-aminomethylpyrrolidine)- platinum(II) and cisplatin.
    Inoue S; Mizuno S; Ito M; Ohnuma T
    Jpn J Cancer Res; 1992 Nov; 83(11):1231-40. PubMed ID: 1483936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro antitumor activity of a new platinum complex, DWA2114R against human tumor cell lines.
    Akamatsu K; Saito H; Tsunenari T; Matsumoto T; Morikawa K; Koizumi M; Mitsui H; Koizumi K
    Anticancer Res; 1993; 13(6A):2261-5. PubMed ID: 8297143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro and in vivo antineoplastic activity of a new platinum antineoplastic agent, (R)-(-)-1,1-cyclobutanedicarboxylate (2-aminomethylpyrrolidine)-platinum (II) (DWA2114R) on freshly separated human tumor cells and human tumor xenografts transplanted in nude mice--a comparison with cis-diammine-dichloroplatinum (CDDP).
    Nio Y; Imai S; Shiraishi T; Tsubono M; Morimoto H; Tseng CC; Tobe T
    Anticancer Res; 1991; 11(2):761-7. PubMed ID: 2064331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potent antitumour activity of (-)-(R)-2-aminomethylpyrrolidine (1,1-cyclobutanedicarboxylato)platinum(II) monohydrate (DWA2114R) against advanced L1210 leukaemia in mice.
    Akamatsu K; Endo K; Matsumoto T; Kamisango K; Morikawa K; Koizumi M; Koizumi K
    Br J Cancer; 1992 Nov; 66(5):827-32. PubMed ID: 1419625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toxicological and tumoricidal evaluations of a new platinum complex, (-)-(R)-2-aminomethylpyrrolidine(1,1-cyclobutanedicarboxylato+ ++)platinum( II) monohydrate, in rats.
    Akamatsu K; Endo K; Matsumoto T; Morikawa K; Koizumi M; Koizumi K; Mitsui H
    Jpn J Cancer Res; 1991 Jun; 82(6):724-31. PubMed ID: 1906857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antitumor activity and cellular accumulation of a new platinum complex, (-)-(R)-2-aminomethylpyrrolidine(1,1-cyclobutanedicarboxylato)platinum( II) monohydrate, in cisplatin-sensitive and -resistant murine P388 leukemia cells.
    Kamisango K; Matsumoto T; Akamatsu K; Morikawa K; Tashiro T; Koizumi K
    Jpn J Cancer Res; 1992 Mar; 83(3):304-11. PubMed ID: 1582895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro antitumor mechanism of a new platinum complex, (-)-(R)-2-aminomethylpyrrolidine(1,1-cyclobutanedicarboxylato+ ++) platinum(II).
    Akamatsu K; Endo K; Matsumoto T; Morikawa K; Koizumi M; Mitsui H; Koizumi K
    Anticancer Res; 1991; 11(1):151-5. PubMed ID: 2018348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishment and characterization of acquired resistance to platinum anticancer drugs in human ovarian carcinoma cells.
    Misawa T; Kikkawa F; Maeda O; Obata NH; Higashide K; Suganuma N; Tomoda Y
    Jpn J Cancer Res; 1995 Jan; 86(1):88-94. PubMed ID: 7737915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the antitumour effects and nephrotoxicity-inducing activities of two new platinum complexes, (-)-(R)-2-aminomethylpyrrolidine(1,1-cyclobutanedicarboxylato+ ++)-platinum (II) monohydrate, and its enantiomeric isomer.
    Matsumoto T; Endoh K; Akamatsu K; Kamisango K; Mitsui H; Koizumi K; Morikawa K; Koizumi M; Matsuno T
    Br J Cancer; 1991 Jul; 64(1):41-6. PubMed ID: 1854626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.